These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 6215979)

  • 21. Combination chemotherapy for advanced colorectal cancer with triazinate, ICRF-159, 5-FU, and methyl-CCNU.
    Vogl SE; Qazi R; Berenzweig M
    Cancer Treat Rep; 1980; 64(10-11):1143-5. PubMed ID: 7459902
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Therapy for gastrointestinal cancer with the nitrosoureas alone and in drug combination.
    Moertel CG; Schutt AJ; Reitemeier RJ; Hahn RG
    Cancer Treat Rep; 1976 Jun; 60(6):729-32. PubMed ID: 954012
    [No Abstract]   [Full Text] [Related]  

  • 23. A time-saving but effective approach to the follow-up of patients after curative surgery for carcinoma of the large bowel.
    Ross AP
    Ann R Coll Surg Engl; 1983 Jan; 65(1):8-10. PubMed ID: 6824311
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A prospective study of isolated human hepatocyte function following liver resection for colorectal liver metastases: the effects of prior exposure to chemotherapy.
    Hewes JC; Riddy D; Morris RW; Woodrooffe AJ; Davidson BR; Fuller B
    J Hepatol; 2006 Aug; 45(2):263-70. PubMed ID: 16635536
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Adjuvant therapy for carcinoma of the colon and rectum.
    Higgins GA
    Int Adv Surg Oncol; 1984; 7():77-111. PubMed ID: 6469380
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Current protocol approaches in large bowel cancer.
    Carter SK
    Semin Oncol; 1976 Dec; 3(4):433-43. PubMed ID: 793018
    [No Abstract]   [Full Text] [Related]  

  • 27. The nitrosoureas--thoughts for the future.
    Carter SK; Wasserman TH
    Cancer Treat Rep; 1976 Jun; 60(6):807-11. PubMed ID: 954014
    [No Abstract]   [Full Text] [Related]  

  • 28. Cancers of the large bowel and hepatobiliary tract.
    Treat J; Woolley PV
    Cancer Chemother Biol Response Modif; 1991; 12():469-89. PubMed ID: 1657090
    [No Abstract]   [Full Text] [Related]  

  • 29. A role for hepatic-directed chemotherapy in colorectal liver metastases.
    Ensminger WD
    J Clin Oncol; 2005 Aug; 23(22):4815-7. PubMed ID: 16009957
    [No Abstract]   [Full Text] [Related]  

  • 30. Breast cancer 1984: state of the art.
    Sledge GW
    Indiana Med; 1984 Dec; 77(12):935-9. PubMed ID: 6394645
    [No Abstract]   [Full Text] [Related]  

  • 31. Perfusion chemotherapy for colorectal liver metastases: a randomized study comparing FUDR against 5-FU/BCNU.
    Schmitz R; Krakamp B; Troidl H
    J Chemother; 1989 Jul; 1(4 Suppl):1216-7. PubMed ID: 16312840
    [No Abstract]   [Full Text] [Related]  

  • 32. [Clinical experiences with UFD-1].
    Furue H
    Gan To Kagaku Ryoho; 1982 Apr; 9(4):672-4. PubMed ID: 6820905
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Variations in responsiveness and survival of clinical subsets of patients with metastatic breast cancer to two chemotherapy combinations.
    Smalley RV; Bartolucci AA
    Eur J Cancer (1965); 1980; Suppl 1():141-6. PubMed ID: 7318861
    [No Abstract]   [Full Text] [Related]  

  • 34. [Drug therapy of cancer].
    Abrahamsen AF; Brennhovd IO; Host H; Kolstad P; Poppe E
    Tidsskr Nor Laegeforen; 1974 Jan; 94(2):106-7. PubMed ID: 4822266
    [No Abstract]   [Full Text] [Related]  

  • 35. Capecitabine and tegafur + uracil: new preparations. Metastatic colorectal cancer: two oral fluorouracil precursors, few advantages.
    Prescrire Int; 2002 Apr; 11(58):44-7. PubMed ID: 11987311
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hypercalcemia in cancer: response to therapy.
    Tashima CK
    Am Fam Physician; 1974 Nov; 10(5):156-9. PubMed ID: 4278933
    [No Abstract]   [Full Text] [Related]  

  • 37. A phase III randomized study comparing doxifluridine and 5-fluorouracil as supportive chemotherapy in advanced and recurrent gastric cancer.
    Kondo K; Sakamoto J; Nakazato H; Koike A; Kitoh T; Hachisuka K; Saji S; Yura J; Nimura Y; Hamajima N; Katoh K; Yamaguchi A; Miya KI; Yamauchi M; Mizuno I; Nagino M; Takagi H
    Oncol Rep; 2000; 7(3):485-90. PubMed ID: 10767356
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Metastatic colorectal cancer. Combination chemotherapy in patients previously treated with 5-fluorouracil.
    Moayeri H; DiBenedetto J; Mittelman A
    N Y State J Med; 1980 Jul; 80(8):1220-4. PubMed ID: 6931307
    [No Abstract]   [Full Text] [Related]  

  • 39. Adenocarcinomas of stomach, pancreas, liver, and biliary tracts. Survival of 328 patients treated with fluoropyrimidine therapy.
    Davis HL; Ramirez G; Ansfield FJ
    Cancer; 1974 Jan; 33(1):193-7. PubMed ID: 4272473
    [No Abstract]   [Full Text] [Related]  

  • 40. A controlled comparison of 5-fluoro-2'-deoxyuridine therapy administered by rapid intravenous injection and by continuous intravenous infusion.
    Moertel CG; Reitemeier RJ; Hahn RG
    Cancer Res; 1967 Mar; 27(3):549-52. PubMed ID: 4225560
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.